Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.

MLA

Padula, William V., et al. “Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.” Applied Health Economics and Health Policy, vol. 16, no. 6, Dec. 2018, pp. 753–63. EBSCOhost, https://doi.org/10.1007/s40258-018-0417-3.

APA

Padula, W. V., Ballreich, J., & Anderson, G. F. (2018). Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry. Applied Health Economics and Health Policy, 16(6), 753–763. https://doi.org/10.1007/s40258-018-0417-3

Chicago

Padula, William V, Jeromie Ballreich, and Gerard F Anderson. 2018. “Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.” Applied Health Economics and Health Policy 16 (6): 753–63. doi:10.1007/s40258-018-0417-3.